In Brief This Week: Source BioScience, Illumina; Verinata Health; PerkinElmer; Altona Diagnostics | GenomeWeb

NEW YORK (GenomeWeb News) – Source BioScience said this week that it has extended its next-generation sequencing services to include the Illumina MiSeq platform. The UK-based genomics services and molecular diagnostics firm said that it is the only commercial provider of the platform in the UK and added that the MiSeq will enable it to apply next-generation sequencing to molecular diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.